Summary of clinicopathologic features of patients and tumors
. | No. of patients . | Percentage of DcR3-positive tumor cells . | P* . | |
---|---|---|---|---|
Less than 10% . | 10% or more . | |||
Age | .88 | |||
Younger than 60 y | 18 | 9 | 9 | |
60 y or older | 50 | 26 | 24 | |
Sex | .49 | |||
Female | 28 | 13 | 15 | |
Male | 40 | 22 | 18 | |
Histologic grade | .53 | |||
Well differentiated | 24 | 12 | 12 | |
Moderately differentiated | 37 | 18 | 19 | |
Poorly differentiated | 7 | 5 | 2 | |
Tumor size | .67 | |||
1 | 15 | 7 | 8 | |
2 to 4 | 53 | 28 | 25 | |
Lymph node | .42 | |||
N0 | 26 | 15 | 11 | |
N1 | 42 | 20 | 22 | |
Distant metastasis, M0 | 68 | 35 | 33 | |
Stage | .28 | |||
S1 to S2 | 25 | 15 | 10 | |
S3 to S4 | 43 | 20 | 23 |
. | No. of patients . | Percentage of DcR3-positive tumor cells . | P* . | |
---|---|---|---|---|
Less than 10% . | 10% or more . | |||
Age | .88 | |||
Younger than 60 y | 18 | 9 | 9 | |
60 y or older | 50 | 26 | 24 | |
Sex | .49 | |||
Female | 28 | 13 | 15 | |
Male | 40 | 22 | 18 | |
Histologic grade | .53 | |||
Well differentiated | 24 | 12 | 12 | |
Moderately differentiated | 37 | 18 | 19 | |
Poorly differentiated | 7 | 5 | 2 | |
Tumor size | .67 | |||
1 | 15 | 7 | 8 | |
2 to 4 | 53 | 28 | 25 | |
Lymph node | .42 | |||
N0 | 26 | 15 | 11 | |
N1 | 42 | 20 | 22 | |
Distant metastasis, M0 | 68 | 35 | 33 | |
Stage | .28 | |||
S1 to S2 | 25 | 15 | 10 | |
S3 to S4 | 43 | 20 | 23 |
Test for chi-square.